Xue et al. reported that in cisplatin- and carboplatin-resistant non-small cell lung cancer cells, the protein levels of FAT10 are increased, and knocking down FAT10 reduces the drug resistance of these cells [13]. The gene discussed is UBD; the disease is non-small cell lung carcinoma.